Unique cytochromes P450 in human brain: implication in disease pathogenesis

Area of Science:

• Biochemistry
• Pharmacology
• Neuroscience

Background:

• Cytochromes P450 (CYPs) are crucial heme proteins for xenobiotic metabolism.
• Human brain CYPs possess distinct biotransformation pathways compared to the liver.
• Understanding brain-specific CYP activity is vital for predicting drug and environmental toxicant effects.

Purpose of the Study:

• To identify and characterize novel, brain-specific cytochrome P450 variants.
• To investigate unique xenobiotic biotransformation pathways in the human brain.
• To explore the functional implications of alternate splicing in brain CYP enzymes.

Main Methods:

• Analysis of alternate splicing in human brain tissue.
• Identification of specific CYP gene variants (e.g., CYP2D7, CYP1A1) in brain versus liver.
• Genotyping to correlate mutations with brain variant expression.
• Functional characterization of novel CYP variants' metabolic activity.

Main Results:

• A novel, functional CYP2D7 splice variant with intron 6 inclusion was identified exclusively in the human brain.
• This brain CYP2D7 variant, linked to the 138delT mutation, uniquely metabolizes codeine to morphine.
• A distinct CYP1A1 splice variant lacking 87 bp of exon 6 was found in the human brain but not the liver.
• Evidence supports the existence of xenobiotic biotransformation pathways in the brain that differ from hepatic pathways.

Conclusions:

• The human brain possesses unique cytochrome P450 enzymes, generated via alternate splicing, with distinct metabolic capabilities.
• These CNS-specific CYP variants, such as brain CYP2D7 and CYP1A1, contribute to novel biotransformation pathways.
• Characterizing these novel enzymes is essential for understanding xenobiotic effects, including drug responses and neurotoxicology.